Simple blood test could spot breast cancer earlier
NCT ID NCT06529614
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new blood test that looks for tiny molecules called MicroRNA in people with breast cancer. The goal is to see how accurate the test is at detecting the disease. Researchers will compare results from 100 participants, including healthy volunteers, to measure the test's sensitivity and specificity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- In-situ detection method for Micro-RNA
- What this could lead to
- If successful, this could provide a new, simpler blood test to help detect breast cancer earlier.
- What could go wrong
- This is a small, early-stage study (100 participants) testing a new method. It may not prove accurate enough for widespread use, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tongji Hospital
RECRUITINGWuhan, Hubei, 430030, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?